| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
STUDY OVERVIEW
This case study reviews the strategy and tactics utilized by Eli Lilly for the
depression indicated product, Cymbalta, to successfully penetrate a crowded
market with a product having a new mechanism of action (MOA). Pharmaceutical
executives can use this study to gather insights into various tactics for
successfully launching a product with a new MOA into a challenging market.
KEY TOPICS
- Business Challenges Addressed
- Market Entry Strategy and Insights
- Use of Third-Party Expertise
- Influencing Key Opinion Leaders
- Tactics to Drive Success
- Focus on Product Efficacy and Safety
- Product Differentiation
- Leveraging Public Relations
- Benefits of Patient Education
- Diversification of Tactics
- Early Lifecycle Management
- Crafting a Durable Brand Promise
- Preparing the Market Through Education
KEY METRICS
- Product Lifecycle Timeline
- Messaging Strategy
- PR Strategy
- Market Revenues Over Time
- Market DTC Expenditures
Industries Profiled: Pharmaceutical
Companies Profiled: Eli Lilly and Company
Features: Metrics, Graphics
Delivery Format: Online PDF Document
METHODOLOGY
The data for this case study was collected utilizing primary research via
executive interviews and supplemental secondary research.
|
